Trial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients
Regeneron Pharmaceuticals Inc. suspended testing of its Covid-19 antibody drug in the sickest hospitalized patients because of a safety concern, the latest setback for antibody-drug trials in patients with the most advanced disease. Regeneron said Friday it is pausing enrollment of hospitalized Covid-19 patients receiving mechanical ventilation or high-flow oxygen, after an independent monitoring committee … Read more